Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Mar'11
Net Sales
231.70
194.52
165.78
140.41
136.66
142.93
105.41
Other Operating Income
2.88
1.28
0.79
1.32
0.99
0.22
0.00
Total Operating income
234.59
195.80
166.57
141.73
137.65
143.15
105.41
Raw Material Cost
72.83
60.23
57.53
53.07
55.99
60.43
41.70
Purchase of Finished goods
15.68
6.27
4.96
3.07
3.18
5.14
2.10
(Increase) / Decrease In Stocks
-1.93
0.58
0.27
0.86
0.98
-0.76
-0.54
Employee Cost
33.58
28.55
25.98
22.82
21.03
19.58
16.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
37.41
30.78
27.23
23.53
22.31
22.69
17.49
Selling and Distribution Expenses
37.38
29.67
26.86
16.66
16.74
18.02
0.00
Other Expenses
10.61
9.05
0.00
0.00
0.00
0.02
15.39
Total Expenditure (Excl Depreciation)
205.57
165.13
142.82
120.02
120.24
125.12
92.46
Operating Profit (PBDIT) excl Other Income
29.02
30.66
23.74
21.71
17.41
18.02
12.95
Other Income
4.83
5.68
4.54
2.94
4.27
4.60
4.80
Operating Profit (PBDIT)
33.85
36.34
28.28
24.66
21.68
22.63
17.75
Interest
0.43
0.31
0.75
1.67
2.48
3.14
0.34
Exceptional Items
2.69
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
36.11
36.03
27.53
22.98
19.20
19.50
17.42
Depreciation
2.87
3.35
3.21
3.60
3.73
3.38
1.81
Profit Before Tax
33.24
32.68
24.32
19.38
15.47
16.12
15.60
Tax
12.10
12.11
9.25
6.94
5.36
6.16
5.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.14
20.57
15.07
12.44
10.12
9.96
10.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
-0.33
-0.22
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.14
20.57
15.07
12.44
10.12
9.63
10.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.14
20.57
15.07
12.44
10.12
9.63
10.21
Equity Capital
2.92
2.92
2.92
2.92
2.92
2.92
3.03
Face Value
2.0
2.0
2.0
2.0
2.0
10.0
10.0
Reserves
0.00
105.82
0.00
86.32
79.34
0.00
98.22
Earnings per share (EPS)
7.23
7.04
5.16
4.26
3.46
3.41
3.44
Diluted Earnings per share
14.47
14.08
10.31
8.51
6.92
33.57
34.43
Operating Profit Margin (Excl OI)
12.37%
15.66%
13.58%
14.59%
12.0%
12.09%
11.8%
Gross Profit Margin
15.39%
18.4%
15.74%
15.45%
13.24%
13.07%
15.86%
PAT Margin
9.01%
10.51%
8.62%
8.36%
6.97%
6.68%
9.5%
Public Share Holdings (%)
0.0%
49.54%
49.54%
49.14%
49.27%
49.29%
51.39%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 12.35% vs 16.72% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 37.50% vs 100.00% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Amrutanjan Healt With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
231.70
0
231.70
Other Operating Income
2.88
0.00
2.88
Total Operating income
234.59
0
234.59
Raw Material Cost
72.83
0
72.83
Purchase of Finished goods
15.68
0
15.68
(Increase) / Decrease In Stocks
-1.93
0
-1.93
Employee Cost
33.58
0
33.58
Power Cost
0.00
0
0.00
Manufacturing Expenses
37.41
0
37.41
Selling and Distribution Expenses
37.38
0
37.38
Other Expenses
10.61
0.00
10.61
Total Expenditure (Excl Depreciation)
205.57
0
205.57
Operating Profit (PBDIT) excl Other Income
29.02
0.00
29.02
Other Income
4.83
0
4.83
Operating Profit (PBDIT)
33.85
0
33.85
Interest
0.43
0
0.43
Exceptional Items
2.69
0
2.69
Gross Profit (PBDT)
36.11
0
36.11
Depreciation
2.87
0
2.87
Profit Before Tax
33.24
0
33.24
Tax
12.10
0
12.10
Provisions and contingencies
0.00
0
0.00
Profit After Tax
21.14
0
21.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
21.14
0
21.14
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.14
0
21.14
Equity Capital
2.92
0
2.92
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
7.23
0
7.23
Diluted Earnings per share
14.47
0
14.47
Operating Profit Margin (Excl OI)
12.37%
0%
0.00
12.37%
Gross Profit Margin
15.39%
0%
0.00
15.39%
PAT Margin
9.01%
0%
0.00
9.01%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 451.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.26% vs 10.96% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 50.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 13.03% vs 12.90% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.35% vs 16.72% in Mar 2024
Annual - Interest
Interest 0.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.50% vs 100.00% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.88%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






